Impact of Additional Monitoring on Pharmacovigilance and Pharmacists' Role: A Scoping Review
This review highlights the need to implement structured AM training programs and develop systematic evaluation frameworks to assess the effectiveness of AM labeling in improving pharmacovigilance practices. Further research is required to optimize AM strategies and reinforce pharmacists' role in post-marketing drug safety.
Authors
- Estíbaliz Goyenechea (ORCID: https://orcid.org/0000-0001-7990-5192)
- Arantxa Isla (ORCID: https://orcid.org/0000-0001-7575-2715)
- Ana del Pozo‐Rodríguez (ORCID: https://orcid.org/0000-0003-2478-0884)
- Amaia Malet‐Larrea (ORCID: https://orcid.org/0000-0002-2809-6249)
- Maria Ángelés Solinís (ORCID: https://orcid.org/0000-0001-9127-0775)
- Xabier Aizpurua‐Arruti (ORCID: https://orcid.org/0000-0001-9028-8236)
- Miguel Ángel Gastelurrutia (ORCID: https://orcid.org/0000-0003-1019-0234)
- Ainhoa Oñatibia‐Astibia (ORCID: https://orcid.org/0000-0002-1726-6943)
Institutions
- University of the Basque Country (ES)
- Universidad de Granada (ES)
- Onkologikoa (ES)
- Centro de Tecnologías Aeronauticas (Spain) (ES)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1002/pds.70201
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eusko Jaurlaritza